As previously stated
Following the completion of an independant review , the refreshed Board are currently reviewing the recommendation and will update shareholders on any hnage reuired to IDTs strategic direction "
Recently re entered and it will be interesting to see what happens. If the recent staff averts are valid then we could be in for an interesting ride in the near term.
DYOR
- Forums
- ASX - By Stock
- IDT
- hard to believe
hard to believe, page-24
Featured News
Add IDT (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
-0.010(8.70%) |
Mkt cap ! $45.13M |
Open | High | Low | Value | Volume |
11.5¢ | 11.5¢ | 10.0¢ | $124.0K | 1.145M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 109533 | 10.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.0¢ | 40772 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 109533 | 0.105 |
5 | 172999 | 0.100 |
1 | 30000 | 0.099 |
2 | 211111 | 0.090 |
1 | 125000 | 0.080 |
Price($) | Vol. | No. |
---|---|---|
0.110 | 40772 | 2 |
0.115 | 250000 | 2 |
0.120 | 151064 | 4 |
0.125 | 250000 | 2 |
0.130 | 202341 | 2 |
Last trade - 15.06pm 13/11/2024 (20 minute delay) ? |
Featured News
IDT (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online